IGF1 and breast cancer: Since activation of this pathway and the subsequent nuclear localization of β-catenin is a hallmark of EMT, we chose to look at the nuclear localization of β-catenin after IGF-1 and latent TGF-β1 treatment of MCF-7 breast cancer cells.